Soligenix invited to present at the virtual investor summit event

Focusing on 25 micro-cap companies with key catalysts and/or strong performance in the current market princeton, n.j. , jan. 19, 2023 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will be presenting at the upcoming virtual investor summit on january 26, 2023.
SNGX Ratings Summary
SNGX Quant Ranking